Knobbe Martens Advises Pacira BioSciences in Exclusive License Agreement with AmacaThera for Novel Long-Acting Analgesic
Agreement will support the development and commercialization of non-opioid therapy for postsurgical pain control IRVINE, Calif., November 4, 2025 – A team from Knobbe Martens advised Pacira BioSciences, Inc. in...
Knobbe Martens Advises Pacira BioSciences in Acquisition of Remaining Equity Stake of GQ Bio
SAN DIEGO, Calif., February 28, 2025 – Pacira BioSciences, Inc., the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced...
Knobbe Martens Team Authors “Recent Developments in Intellectual Property Law 2022” For ABA Business Law Today Section
Knobbe Martens attorneys Julia Hanson, Alistair McIntyre, Nyja Prior and Michelle Ziperstein co-authored the article “Recent Developments in Intellectual Property Law 2022” for the ABA’s Business Law Today section. Partner...
Knobbe Martens Welcomes New Class of Associates
Knobbe Martens announces its continued commitment to providing the highest quality legal services with the addition of 30 new Associates firmwide. “Our new associates have a wide range of talents...
